Deep knowledge on 
 small-molecule drugs and 
 the 110,000 global patents 
 covering them 

Free Patent Expiration Alerts

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Colchicine - Generic Drug Details

« Back to Dashboard
Colchicine is the generic ingredient in seven branded drugs marketed by Hikma Intl Pharms, Takeda Pharms Usa, Ingenus Pharms Nj, Impax Labs, Beecham, Watson Labs, Sandoz, Ani Pharms Inc, Lederle, and Merck, and is included in twelve NDAs. There are eighteen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for colchicine. Nine suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: colchicine

Drug Master File Entries: see list15
Suppliers / Packaging: see list9
Therapeutic Class:Antigout Agents
Formulation / Manufacturing:see details

Pharmacology for Ingredient: colchicine

Tentative approvals for COLCHICINE

Applicant Application No. Form Dosage

Clinical Trials for: colchicine

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
colchicine; probenecid
TABLET;ORAL085552-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Takeda Pharms Usa
TABLET;ORAL022352-001Jul 29, 2009RXYes7,935,731<disabled> <disabled>
Ingenus Pharms Nj
colchicine; probenecid
TABLET;ORAL040618-001May 13, 2008RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: colchicine

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,445,541Methods for concomitant administration of colchicine and a second active agent<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Connect with Social Media: